Recorded device evidence

ASTRASONIC SPIROMETER, MODEL 29-8000 (K092813): indications, design and recorded evidence

The acquired K092813 file contains product-specific indications and users, design and operating principle, recorded comparison and differences, performance evidence actually described sections. Compare these dated manufacturer statements with your own indication and design before commissioning evidence work. They describe this submission; they do not prescribe your testing, validate performance independently or establish a suitable predicate.

Evidence retrieved 2026-10-08. Source versions and topic-specific limits are listed below.

Computed exact-code research

This decision beside its recorded product-code cohort

The 2021–2025 complete-year cohort contains 10 selected decisions under primary code BZG. 10 have valid reported receipt/decision pairs; 0 pairs are missing or invalid.

No quartiles are displayed: this complete-year cohort has fewer than 20 valid pairs.

The table shows the named decision and up to four latest exact-code research records through 2026-09-27. It can include partial-year records outside the complete-year cohort. The quartiles above use the full stated cohort, not this displayed selection.

Research recordRecorded deviceReceipt → decisionCalendar elapsed daysRecorded submission type
K092813 ↗ · this pageASTRASONIC SPIROMETER, MODEL 29-80002009-09-14 → 2010-07-16305Traditional
K251777 ↗MESI mTABLET SPIRO2025-06-10 → 2026-03-02265Traditional
K241843 ↗TD-7301 Spirometer (TD-7301)2024-06-26 → 2024-11-20147Traditional
K231416 ↗Air Next (NVD-02)2023-05-16 → 2024-01-18247Traditional
K230501 ↗Spirobank Oxi2023-02-24 → 2023-12-15294Traditional

Use this comparison: select a record to investigate, read its actual indications and design, and document differences. A shared code or elapsed period cannot establish its relevance to your device.

Calendar elapsed days are not active FDA review time, a promised schedule or a success probability. The selection includes only the stated recorded decisions, not all applications. Latest records can postdate the named historical decision and are contextual research, not its predicates. Shared codes, summaries and observed records do not prove equivalence, current market availability, buyer applicability or predicate suitability.

Calculation, selection and source versions

Reuse the complete-endpoint exact-primary-code, documented SE-decision cohort and its stated cutoff/window. Retain its type-7 quartiles only when at least 20 valid date pairs are present. Independently subtract the named official record’s receipt date from its decision date; missing or negative pairs remain unknown. Show up to four latest exact-code research records, excluding the named ID. Parent analysis hash, source snapshots and calculation versions are retained.

Calculation: fda-named-decision-cohort-context-1; cutoff 2026-09-27; 0 parent records excluded; units record counts; calendar elapsed days.

Source snapshots: 5a86994ba49a37e71e09be96803fd51981c6c43eaa96caab41aea2b188bfe002.

Read beyond the decision row

Recorded evidence and differences to investigate

The summary is manufacturer-submitted context hosted by FDA. Negative/no-study statements are preserved. Evidence themes are not binding legal requirements.

Short opening excerpts identify the source sections. Read the linked original for the full study context, negative statements, tables and limitations. Public quotations are limited to 120 words per acquired summary; the internal evidence packet retains exact section ranges for review.

Indications and users

K092813 · PDF page 1 ↗ Source 2

The     SDI           AstraSonic    Spirometer        is a freestanding        laboratory
                                                                                                                                    instrument      for       performing        basic        lung      function      tests        in adults        and
                                                                                                                                    children    over   the     age        of four  years.

The excerpt is shortened at a complete statement. Read the complete section in the original PDF before interpreting the evidence.

Compare with your product: Compare the recorded indication, population, body site and use environment with your proposed label. Record each change instead of assuming the primary code settles intended use.

Design and operating principle

K092813 · PDF page 1 ↗ Source 2

The  AstraSonic          Diagnostic      Spirometer        is a hand-held     portable
                                                                                                                                     diagnostic   spirometer   for     the       measurement      of     patient   breath         flow
                                                                                                                                     and    volume.       The       device      uses     an        ultrasonic       transducer   that
                                                                                                                                     measures  flow.

The excerpt is shortened at a complete statement. Read the complete section in the original PDF before interpreting the evidence.

Compare with your product: Compare physical design, materials, energy, accessories and operating principle with your design. Ask which documented differences change the evidence scope.

Recorded comparison and differences

K092813 · PDF page 2 ↗ Source 3

The     AstraSonic        spirometer        has   the       same      technological
                                                                                       characteristics     as    the       predicate        device,    except    that     the     predicate
                                                                                       device    has       a disposable   transducer      mouthpiece       that       is an
                                                                                       integral        part       of the       circuit.

The excerpt is shortened at a complete statement. Read the complete section in the original PDF before interpreting the evidence.

Compare with your product: The summary’s comparison is a manufacturer statement about that submission. Investigate the actual design differences and cited records before considering any comparator or predicate.

Performance evidence actually described

K092813 · PDF page 2 ↗ Source 3

A direct      comparison       of   the       Astrasonic     spirometer      and      the
                                                                                       predicate          device  was      made         using     the     26      waveforms        described
                                                                                       by        the  American       Thoracic         Society   to         determine       substantial
                                                                                       equivalence.

Compare with your product: The source labels this section as performance data. Determine which described evidence is bench, software, biological or clinical from the actual narrative and original tables; the section label alone does not settle that distinction or prescribe your testing.

Extraction selection and limits

Select observed whole-line section headings or explicit colon-delimited inline labels on readable PDF pages, including the explicitly documented heading-spacing variants in this parser version. Preserve the original heading, character ranges and layout; do not repair excerpt text. Exclude letter boilerplate and uncertain pages. Stop at observed table headings; do not infer table columns or scalar results from layout text. Multi-column or suspicious split-numeric excerpts are excluded until reviewed alternate extraction is available. Original layout records remain retained; any alternate text has its own extractor-version locator and requires original-page review. For each dimension, prefer usable versioned alternate text where available, selecting its longest usable excerpt; otherwise select the longest usable original-layout excerpt. Ties preserve source order. Bounded to 64 PDF pages and 3,500 characters per section. This is a selection, not a complete dossier analysis.

Excluded extraction items: {}.

Known facts and deciding inputs

Known context: US. Confirm the organisation’s role, relevant activities and markets against the cited criteria.

Source factRecorded valueWhat to check
510(k) identifierK092813 [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Generic device categoryASTRASONIC SPIROMETER, MODEL 29-8000 [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Recorded applicantSdi Diagnostics, Inc. [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
FDA product codeBZG [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Decision date2010-07-16 [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Recorded decision codeSESE [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Submission typeTraditional [1]Dated official record fact; not proof of current commercial availability or applicability to another device.
Receipt date2009-09-14 [1]Dated official record fact; not proof of current commercial availability or applicability to another device.

Prepare a differences and evidence worksheet

Use this checklist to gather your business or product details before speaking with a specialist. The items below explain what to record and suggest useful supporting documents. You can add your own answers in the editable project brief.

  1. Indications and users — what differs in our product?

    Compare the recorded indication, population, body site and use environment with your proposed label. Record each change instead of assuming the primary code settles intended use.

    Useful evidence: Our proposed indication, user/population and use environment beside this exact recorded indication.

  2. Design and operating principle — what differs in our product?

    Compare physical design, materials, energy, accessories and operating principle with your design. Ask which documented differences change the evidence scope.

    Useful evidence: Design description, materials/components, accessory list and a differences matrix.

  3. Recorded comparison and differences — what differs in our product?

    The summary’s comparison is a manufacturer statement about that submission. Investigate the actual design differences and cited records before considering any comparator or predicate.

    Useful evidence: Feature-by-feature differences and the underlying cited documents; no automated predicate selection.

  4. Performance evidence actually described — what differs in our product?

    The source labels this section as performance data. Determine which described evidence is bench, software, biological or clinical from the actual narrative and original tables; the section label alone does not settle that distinction or prescribe your testing.

    Useful evidence: The cited narrative and full tables, underlying protocols/results and a reviewed comparison with the proposed product.

Work packages and dependencies

Questions for providers

Sources and data dates

Read the official document in context. The audit details identify the precise locators and preserved versions used for this page.

FDA openFDA — 510(k) decision records ↗

2026-10-05 · retrieved 2026-10-06

Audit details: precise locators and snapshot identifiers

Source key D01 · snapshot 5a86994ba49a37e71e09be96803fd51981c6c43eaa96caab41aea2b188bfe002

  • [1] device-510k-0001-of-0001.json:results[19397] · record b68a3f613f97a872c2dcce817521fde4c6b91b5508582295eed3d545ed9137d1
  • [4] Complete results array / fda-decision-context:K092813 · record whole dataset partition

FDA 510(k) summary — K092813 ↗

Thu, 05 Aug 2010 18:09:05 GMT · retrieved 2026-10-08

Audit details: precise locators and snapshot identifiers

Source key D02 · snapshot 4f7a4b59a38371fc2927607ce1aef77a7770aa3fdb4f97cc1b516f5d32e86036

  • [2] PDF page 1 · record fe4ecf1496fc2374ecde0bd8726ff9aac96eef15e8eb61f55c9ee02c33cefb7a
  • [3] PDF page 2 · record 34fd0a29c028cc5e83af21e2015d7d81229296aaa192fbff242360ff573663e2

Prepare an editable project brief

Confirm the facts, scope and contact preference before sharing your project. Preparing this page sends no provider outreach.

Choose work packages to discuss

Compare FDA 510(k) Submission Services